Table 3 Clinical and pathological ovarian cancer characteristics determined by the BRCA1 gene status

Median (range) age at diagnosis in years

56 (28–85)

47 (39–70)

−2.859^a

0.004

 ▪ 0

15

4

 ▪ Other

93

13

0.44^b

0.51

 ▪ Early (I, II)

22

3

 ▪ Advanced (III,IV)

86

14

0.07^b

0.95

 ▪ With paclitaxel

97

16

 ▪ Without paclitaxel

11

1

0.01^b

0.91

 ▪ With cisplatin

47

8

 ▪ With carboplatin

61

9

0.1^c

0.75

 ▪ Serous

57

11

 ▪ Other

51

6

0.84^c

0.36

 ▪ 1 and 2

38

7

 ▪ 3 and unspecified

70

10

0.23^c

0.63

 ▪ Optimal (<1 cm)

68

9

 ▪ Suboptimal (>1 cm)

40

8

0.62^c

0.43